The peptide therapeutics market in North America and beyond is evolving fast, and 2025 is set to be a groundbreaking year.
Whether you’re a researcher involved in peptide drug clinical trials, an investor in different pharmaceutical companies, or just curious about the future of medicine and drug discovery, understanding various peptide therapeutics market trends will…
Shots:
AstraZeneca & CSPC have partnered to discover & develop pre-clinical candidates for multiple targets across chronic diseases, incl. a pre-clinical oral small molecule for immunological diseases
As per the deal, CSPC will receive $110M upfront as well as ~$1.62B in development & ~$3.6B in sales milestones with net sales-based single digit royalties, while AstraZeneca…
Shots:
Recently, Qiagen entered into a collaboration agreement with AstraZeneca to develop companion diagnostics for chronic diseases using Qiagen’s QIAstat-Dx system
Today, at PharmaShots, we are joined by Richard Watts from Qiagen, who sheds light on their collaboration agreements with AstraZeneca and Eli Lilly, leveraging their syndromic testing platform, QIAstat-Dx
Qiagen has partnered with over…
Aging is a natural part of life, but it doesn't mean giving up on good health and vitality. Many men worry about heart disease and other chronic diseases as they get older, but there are ways to tackle these concerns. Making small lifestyle changes can significantly improve men’s health as they age, leading to a…

